Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata may be linked to scalp microbiome differences, suggesting potential treatments with prebiotics, probiotics, and postbiotics.

Different types of resting melanocyte stem cells have unique characteristics and vary in their potential to become other cells.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Curcumin shows promise in reducing pain and inflammation, but more research is needed.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

The new drug delivery system effectively targets lung cancer cells.

Using existing drugs for new purposes can effectively treat infections resistant to multiple antibiotics.

Re-evaluating minoxidil, reducing sodium intake, and addressing arteriolar hypertrophy can improve hypertension management.

Bioelectronic nanogenerators show promise for cancer treatment but need better understanding and development.

Modified frameworks with stearic acid enhance drug delivery and promote hair growth.

Minoxidil helps restore thymus size in 22q11.2 deletion syndrome.

Cannabidiol shows promise as an effective treatment for acne.

Topical peptides may offer safer, effective pain relief and healing for wounds.

Keratin 15 helps maintain skin cell growth and repair.

3D culture better preserves sweat gland cell identity than 2D culture.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Softer hydrogels help wounds heal better with less scarring.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Special cells can help regrow hair in alopecia areata.

Drug repositioning offers a cost-effective, lower-risk way to treat diseases and pandemics like COVID-19.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Cow placenta extract may help hair grow by increasing a growth factor but is less effective than minoxidil.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Integrating biological networks improves drug repurposing and ADR prediction.